<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">28219154</PMID><DateCompleted><Year>2017</Year><Month>09</Month><Day>04</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0253-9624</ISSN><JournalIssue CitedMedium="Print"><Volume>51</Volume><Issue>2</Issue><PubDate><Year>2017</Year><Month>Feb</Month><Day>06</Day></PubDate></JournalIssue><Title>Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]</Title><ISOAbbreviation>Zhonghua Yu Fang Yi Xue Za Zhi</ISOAbbreviation></Journal><ArticleTitle>[Human enterovirus infection status and clinical characteristics of 274 patients with viral encephalitis in Henan Province, 2011-2012].</ArticleTitle><Pagination><StartPage>150</StartPage><EndPage>153</EndPage><MedlinePgn>150-153</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3760/cma.j.issn.0253-9624.2017.02.010</ELocationID><Abstract><AbstractText><b>Objective:</b> To investigate human enterovirus (HEV) infection and clinical characteristics of viral encephalitis patients in Pingdingshan, Henan Province. <b>Methods:</b> Cerebrospinal fluid specimens and epidemiological information were collected from 274 viral encephalitis patients in the departments of pediatrics and neurology in hospitals in Pingdingshan, Henan Province, from April 2011 to August 2012. Patients with bacterial infections were excluded from the study. Demographic information was collected by questionnaires and clinical information was mainly obtained from hospital examinations. Viral RNA was extracted using magnetic bead extraction. Real-time RT-PCR was then performed for HEV, CV-A16, and EV-A71 testing. SPSS statistical software was statistical analyses. Significant differences were determined using the chi-squared test (<i>P&lt;</i>0.05). <b>Results:</b> Among 274 cases of viral encephalitis, 180 cases (65.7%) were male and 94 cases were female (34.3%). The median age was 2.17 years. Approximately 61.3% (168) of patients were younger than 3 years of age. A total of 107 (39.1%), 2 (0.7%), and 42 (15.3%) cases were positive for HEV, CV-A16, and EV-A71, respectively. Eleven patients were younger than 6 months of age and one patient was co-infected with HEV and EV-A71. In the&lt;3, 3-5, 6-15, and&gt;15 years old age groups, HEV infections comprised 31.5% (53/168), 52.9% (18/34), 53.0% (35/66), and 16.7% (1/6) (&#x3c7;(2)=13.10, <i>P=</i>0.003), respectively. The EV-A71 infection rates were 17.9% (30/168), 23.5% (8/34), 6.1% (4/66), and 0 (&#x3c7;(2)=8.04, <i>P=</i>0.045), respectively. The other enterovirus (OEV) infection rates were 12.5% (21/168), 29.4% (10/34), 48.5% (32/66), and 16.7% (1/6) (&#x3c7;(2)=35.19, <i>P&lt;</i>0.001), respectively. The rate of vomiting in OEV and EV-A71 infected patients was 73% (44/60) and 26% (11/42), respectively, while the frequency of skin rash in OEV and EV-A71 infected patients was 32% (19/60) and 79% (33/42), respectively. Approximately 95% (99/104) of patients infected with HEV had a fever, and the breathing rhythm change rate was 19% (20/104), which was lower than that of patients without HEV infection (36.8% (60/163)) (&#x3c7;(2)=9.35, <i>P=</i>0.002). <b>Conclusion:</b> In Pingdingshan, HEV was a major causative agent of viral encephalitis and the rate of OEV infection was high, especially in children aged 3-15 years old. Fever was a common clinical symptom of patients infected with HEV. Patients infected with OEV primarily exhibited vomiting symptoms and EV-A71 infected patients showed skin rash.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>H X</ForeName><Initials>HX</Initials><AffiliationInfo><Affiliation>Henan Center for Disease Control and Prevention, Zhengzhou 450016, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>J J</ForeName><Initials>JJ</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Y</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>X Y</ForeName><Initials>XY</Initials></Author><Author ValidYN="Y"><LastName>You</LastName><ForeName>A G</ForeName><Initials>AG</Initials></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>B L</ForeName><Initials>BL</Initials></Author></AuthorList><Language>chi</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Zhonghua Yu Fang Yi Xue Za Zhi</MedlineTA><NlmUniqueID>7904962</NlmUniqueID><ISSNLinking>0253-9624</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060085" MajorTopicYN="N">Coinfection</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018792" MajorTopicYN="N">Encephalitis, Viral</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="Y">cerebrospinal fluid</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060888" MajorTopicYN="N">Real-Time Polymerase Chain Reaction</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="chi"><AbstractText><b>&#x76ee;&#x7684;&#xff1a;</b> &#x5206;&#x6790;&#x6cb3;&#x5357;&#x7701;&#x90e8;&#x5206;&#x75c5;&#x6bd2;&#x6027;&#x8111;&#x708e;&#x60a3;&#x8005;&#x4eba;&#x7c7b;&#x80a0;&#x9053;&#x75c5;&#x6bd2;&#xff08;HEV&#xff09;&#x7684;&#x611f;&#x67d3;&#x60c5;&#x51b5;&#x53ca;&#x5176;&#x4e34;&#x5e8a;&#x7279;&#x5f81;&#x3002; <b>&#x65b9;&#x6cd5;&#xff1a;</b> &#x9009;&#x53d6;2011&#x5e74;4&#x6708;&#x81f3;2012&#x5e74;8&#x6708;&#x5728;&#x6cb3;&#x5357;&#x7701;&#x5e73;&#x9876;&#x5c71;&#x5e02;3&#x6240;&#x533b;&#x9662;&#x5185;&#x513f;&#x79d1;&#x548c;&#x795e;&#x7ecf;&#x5185;&#x79d1;&#x88ab;&#x8bca;&#x65ad;&#x4e3a;&#x75c5;&#x6bd2;&#x6027;&#x8111;&#x708e;&#x7684;&#x60a3;&#x8005;&#x4e3a;&#x7814;&#x7a76;&#x5bf9;&#x8c61;&#xff0c;&#x540c;&#x65f6;&#x6392;&#x9664;&#x7ec6;&#x83cc;&#x611f;&#x67d3;&#x8005;&#xff0c;&#x5171;274&#x4f8b;&#x3002;&#x91c7;&#x7528;&#x81ea;&#x884c;&#x8bbe;&#x8ba1;&#x7684;&#x8c03;&#x67e5;&#x95ee;&#x5377;&#x6536;&#x96c6;&#x60a3;&#x8005;&#x7684;&#x57fa;&#x672c;&#x4fe1;&#x606f;&#xff0c;&#x533b;&#x7597;&#x673a;&#x6784;&#x68c0;&#x67e5;&#x7ed3;&#x679c;&#x4e3b;&#x8981;&#x6765;&#x6e90;&#x4e8e;&#x533b;&#x9662;&#x60a3;&#x8005;&#x8d44;&#x6599;&#x3002;&#x91c7;&#x96c6;&#x7814;&#x7a76;&#x5bf9;&#x8c61;&#x7684;&#x8111;&#x810a;&#x6db2;&#x6807;&#x672c;&#xff0c;&#x4f7f;&#x7528;&#x78c1;&#x73e0;&#x6cd5;&#x81ea;&#x52a8;&#x6838;&#x9178;&#x63d0;&#x53d6;&#x4eea;&#x8fdb;&#x884c;&#x75c5;&#x6bd2;RNA&#x63d0;&#x53d6;&#xff0c;&#x91c7;&#x7528;&#x5b9e;&#x65f6;&#x8367;&#x5149;RT-PCR&#x8bd5;&#x5242;&#x8fdb;&#x884c;HEV&#x6838;&#x9178;&#x68c0;&#x6d4b;&#xff0c;&#x91c7;&#x7528;&#x5206;&#x578b;&#x8bd5;&#x5242;&#x8fdb;&#x884c;&#x80a0;&#x9053;&#x75c5;&#x6bd2;A71&#x578b;&#xff08;EV-A71&#xff09;&#x3001;&#x67ef;&#x8428;&#x5947;&#x75c5;&#x6bd2;A16&#x578b;&#xff08;CV-A16&#xff09;&#x7684;&#x6838;&#x9178;&#x68c0;&#x6d4b;&#x3002;&#x91c7;&#x7528;&#x3c7;(2)&#x68c0;&#x9a8c;&#x6bd4;&#x8f83;&#x4e0d;&#x540c;&#x5e74;&#x9f84;&#x7814;&#x7a76;&#x5bf9;&#x8c61;&#x611f;&#x67d3;HEV&#x5dee;&#x5f02;&#x3002; <b>&#x7ed3;&#x679c;&#xff1a;</b> 274&#x4f8b;&#x75c5;&#x6bd2;&#x6027;&#x8111;&#x708e;&#x60a3;&#x8005;&#x4e2d;&#xff0c;&#x7537;&#x6027;&#x4e3a;180&#x4f8b;&#xff08;65.7%&#xff09;&#xff0c;&#x5973;&#x6027;&#x4e3a;94&#x4f8b;&#xff08;34.3%&#xff09;&#xff1b;&#x5e74;&#x9f84;&#x4e2d;&#x4f4d;&#x6570;&#x4e3a;2.17&#x5c81;&#xff0c;&#x4e3b;&#x8981;&#x96c6;&#x4e2d;&#x5728;3&#x5c81;&#x4ee5;&#x4e0b;&#xff08;61.3%&#xff0c;168&#x4f8b;&#xff09;&#x3002;HEV&#x603b;&#x611f;&#x67d3;&#x7387;&#x4e3a;39.1%&#xff08;107&#x4f8b;&#xff09;&#xff0c;CV-A16&#x611f;&#x67d3;&#x7387;&#x4e3a;0.7%&#xff08;2&#x4f8b;&#xff09;&#xff0c;EV-A71&#x611f;&#x67d3;&#x7387;&#x4e3a;15.3%&#xff08;42&#x4f8b;&#xff09;&#x3002;&#x2264;6&#x6708;&#x9f84;&#x60a3;&#x8005;&#x5171;11&#x4f8b;&#xff0c;&#x5176;&#x4e2d;HEV&#x611f;&#x67d3;&#x8005;&#x4e3a;1&#x4f8b;&#xff0c;&#x5c5e;EV-A71&#x578b;&#x522b;&#xff1b;&lt;3&#x3001;3~5&#x3001;6~15&#x3001;&gt;15&#x5c81;&#x60a3;&#x8005;HEV&#x603b;&#x611f;&#x67d3;&#x7387;&#x5206;&#x522b;&#x4e3a;32%&#xff08;53/168&#xff09;&#x3001;53%&#xff08;18/34&#xff09;&#x3001;53%&#xff08;35/66&#xff09;&#x3001;1/6&#xff08;&#x3c7;(2)=13.10&#xff0c;<i>P=</i>0.003&#xff09;&#xff1b;EV-A71&#x611f;&#x67d3;&#x7387;&#x5206;&#x522b;&#x4e3a;18%&#xff08;30/168&#xff09;&#x3001;24%&#xff08;8/34&#xff09;&#x3001;6%&#xff08;4/66&#xff09;&#x3001;0&#xff08;&#x3c7;(2)=8.04&#xff0c;<i>P=</i>0.045&#xff09;&#xff1b;&#x5176;&#x4ed6;HEV&#xff08;OEV&#xff09;&#x611f;&#x67d3;&#x7387;&#x5206;&#x522b;&#x4e3a;13%&#xff08;21/168&#xff09;&#x3001;29%&#xff08;10/34&#xff09;&#x3001;49%&#xff08;32/66&#xff09;&#x3001;1/6&#xff08;&#x3c7;(2)=35.19&#xff0c;<i>P&lt;</i>0.001&#xff09;&#x3002;OEV&#x548c;EV-A71&#x611f;&#x67d3;&#x8005;&#x5455;&#x5410;&#x6bd4;&#x4f8b;&#x5206;&#x522b;&#x4e3a;73%&#xff08;44/60&#xff09;&#x548c;26%&#xff08;11/42&#xff09;&#xff0c;&#x5176;&#x51fa;&#x73b0;&#x76ae;&#x75b9;&#x6bd4;&#x4f8b;&#x5206;&#x522b;&#x4e3a;32%&#xff08;19/60&#xff09;&#x548c;79%&#xff08;33/42&#xff09;&#x3002;HEV&#x611f;&#x67d3;&#x8005;&#x53d1;&#x70ed;&#x6bd4;&#x4f8b;&#x4e3a;95%&#xff08;99/104&#xff09;&#xff0c;&#x5176;&#x51fa;&#x73b0;&#x547c;&#x5438;&#x8282;&#x5f8b;&#x6539;&#x53d8;&#x75c7;&#x72b6;&#x7684;&#x6bd4;&#x4f8b;[19%&#xff08;20/104&#xff09;]&#x4f4e;&#x4e8e;&#x672a;&#x611f;&#x67d3;&#x8005;[36.8%&#xff08;60/163&#xff09;]&#xff08;&#x3c7;(2)=9.35&#xff0c;<i>P=</i>0.002&#xff09;&#x3002; <b>&#x7ed3;&#x8bba;&#xff1a;</b> &#x6cb3;&#x5357;&#x7701;&#x5e73;&#x9876;&#x5c71;&#x5730;&#x533a;&#x75c5;&#x6bd2;&#x6027;&#x8111;&#x708e;&#x60a3;&#x8005;&#x4e2d;HEV&#x611f;&#x67d3;&#x7387;&#x8f83;&#x9ad8;&#xff0c;&#x5c24;&#x5176;&#x662f;3~15&#x5c81;&#x60a3;&#x8005;&#x3002;HEV&#x611f;&#x67d3;&#x8005;&#x53d1;&#x70ed;&#x6bd4;&#x4f8b;&#x8f83;&#x9ad8;&#xff0c;&#x4e3a;&#x666e;&#x904d;&#x4e34;&#x5e8a;&#x8868;&#x73b0;&#xff1b;OEV&#x611f;&#x67d3;&#x8005;&#x8f83;&#x5bb9;&#x6613;&#x51fa;&#x73b0;&#x5455;&#x5410;&#x75c7;&#x72b6;&#xff0c;EV-A71&#x611f;&#x67d3;&#x8005;&#x8f83;&#x5bb9;&#x6613;&#x51fa;&#x73b0;&#x76ae;&#x75b9;&#x3002;.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Clinical symptoms</Keyword><Keyword MajorTopicYN="N">Encephalitis, viral</Keyword><Keyword MajorTopicYN="N">Enterovirus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28219154</ArticleId><ArticleId IdType="doi">10.3760/cma.j.issn.0253-9624.2017.02.010</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>